Business Summary
Longduoduo Company Limited is a Nevada holding company with no operations of its own; all business is conducted through seven PRC operating subsidiaries held via a Hong Kong intermediary. The subsidiaries act as a sales agent/commission-based distributor (and, to a shrinking degree, a principal reseller) of preventive healthcare services in Inner Mongolia, China, focused on preventing cardiovascular and cerebrovascular diseases such as myocardial infarction, cerebral infarction, and hemiplegia.
Products & Services
- Commissioned sales of health maintenance services developed and provided by third-party operator Inner Mongolia Honghai Health Management Co., Ltd. ("Honghai") under Sales Agency Agreements
- Principal (buy-resell) sales of preventive healthcare treatments sourced from licensed third-party hospitals/clinics, including:
- Meridian-regulating and Consciousness-restoring Iatrotechnics (traditional Chinese medicine, anti-thrombotic)
- Double Blood Purification (blood filtration for cardiovascular/cerebrovascular disease)
- Immunological Ozonated Autohemotherapy (ozone therapy device blood treatment)
- PRP (platelet-rich plasma) therapy for joint inflammation/injury -...
AI-generated summary of Item 1 (Business) from the 10-K filed Sep 26, 2025 — View filing on SEC.gov. May contain errors — refer to the filing for authoritative information.
Across SEC filings
Annual results · 10-K
Fiscal 2026- Revenue
- $1.8M
- Net loss
- -$578.6K
As reported in the fiscal 2026 annual report, filed Sep 30, 2026.